Posts

UPC Court of Appeal tackles broad functional antibody claims (UPC_CoA_529/2024)

Insufficiency resulting from mutually exclusive definitions: The repercussive effect of dependent claims (T 0878/23)

Patentee's own post-published data undermines the credibility of their broad cat antibody patent (T 0709/23)

UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21

The plausibility of diagnostic inventions: No data, no patent (T 0589/22)

To infinity and beyond! The sufficiency requirements for open-ended ranges (T 1977/22)

Epitope claims stand firm: Board of Appeal upholds functional antibody patent despite insufficiency attack (T 0326/22)

Fishy evidence: Do we have the right sufficiency standard for therapeutic use? (T 1057/22)